Direct-To-Final FDAMA Reporting Rule To Be Effective Sept. 24
This article was originally published in The Gray Sheet
Executive Summary
FDA is receiving comments until July 27 on a proposed direct-to-final rule implementing the FDA Modernization Act provision that modifies the medical device reporting regulations. The rule becomes final Sept. 24 barring any substantive negative comments.